COVID-19, or coronavirus, is affecting all of us. However, people who are immunocompromised due to medications for their rheumatic diseases may be considered “high risk” for infection.
In this video, Laura Hummers, the clinical director of Johns Hopkins Rheumatology, and Vicky Ruffing, Director of Patient Education, answer some of your most pressing questions about how this outbreak could affect rheumatic patients.
The information in this video is current as of March 16, 2020. Patients should stay in touch with their health care providers and updated information from the Centers for Disease Control.